<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fluoropharma Medical — News on 6ix</title>
    <link>https://6ix.com/company/fluoropharma-medical</link>
    <description>Latest news and press releases for Fluoropharma Medical on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 18 Oct 2016 15:11:44 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/fluoropharma-medical" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835707d78dffbe2df0f4b2d.webp</url>
      <title>Fluoropharma Medical</title>
      <link>https://6ix.com/company/fluoropharma-medical</link>
    </image>
    <item>
      <title>FluoroPharma and Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-and-philips-collaborate-on-image-management-for-cardiopet-phase-ii-clinical-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-and-philips-collaborate-on-image-management-for-cardiopet-phase-ii-clinical-trial</guid>
      <pubDate>Tue, 18 Oct 2016 15:11:44 GMT</pubDate>
      <description>FluoroPharma and Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial.</description>
    </item>
    <item>
      <title>FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-announces-cardiopet-phase-ii-results-at-the-21st-american-society-of-nuclear-cardiology-asnc-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-announces-cardiopet-phase-ii-results-at-the-21st-american-society-of-nuclear-cardiology-asnc-meeting</guid>
      <pubDate>Wed, 28 Sep 2016 16:51:47 GMT</pubDate>
      <description>FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting.</description>
    </item>
    <item>
      <title>FluoroPharma Medical Announces Details for Investor Call on June 22, 2016</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-medical-announces-details-for-investor-call-on-june-22-2016</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-medical-announces-details-for-investor-call-on-june-22-2016</guid>
      <pubDate>Fri, 17 Jun 2016 18:37:08 GMT</pubDate>
      <description>FluoroPharma Medical Announces Details for Investor Call on June 22, 2016.</description>
    </item>
    <item>
      <title>FluoroPharma Announces a Letter of Intent to Acquire Ground Fluor Pharmaceuticals</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-announces-a-letter-of-intent-to-acquire-ground-fluor-pharmaceuticals</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-announces-a-letter-of-intent-to-acquire-ground-fluor-pharmaceuticals</guid>
      <pubDate>Thu, 09 Jun 2016 17:00:09 GMT</pubDate>
      <description>FluoroPharma Announces a Letter of Intent to Acquire Ground Fluor Pharmaceuticals.</description>
    </item>
    <item>
      <title>FluoroPharma Enters Development and Commercialization Agreement for China and Canada</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-enters-development-and-commercialization-agreement-for-china-and-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-enters-development-and-commercialization-agreement-for-china-and-canada</guid>
      <pubDate>Mon, 06 Jun 2016 14:29:30 GMT</pubDate>
      <description>FluoroPharma Enters Development and Commercialization Agreement for China and Canada.</description>
    </item>
    <item>
      <title>FluoroPharma Medical Announces Acceptance of CardioPET Data for Presentation at the 21st Scientific Meeting of the American Society of Nuclear Cardiology</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-medical-announces-acceptance-of-cardiopet-data-for-presentation-at-the-21st-scientific-meeting-of-the-american-society-of-nuclear-cardiology</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-medical-announces-acceptance-of-cardiopet-data-for-presentation-at-the-21st-scientific-meeting-of-the-american-society-of-nuclear-cardiology</guid>
      <pubDate>Wed, 25 May 2016 14:11:03 GMT</pubDate>
      <description>FluoroPharma Medical Announces Acceptance of CardioPET Data for Presentation at the 21st Scientific Meeting of the American Society of Nuclear Cardiology.</description>
    </item>
    <item>
      <title>FluoroPharma Medical Announces Details for Investor Call on January 6th</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-medical-announces-details-for-investor-call-on-january-6th</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-medical-announces-details-for-investor-call-on-january-6th</guid>
      <pubDate>Tue, 05 Jan 2016 17:32:31 GMT</pubDate>
      <description>FluoroPharma Medical Announces Details for Investor Call on January 6th.</description>
    </item>
    <item>
      <title>FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/fluoropharma-names-dr-thomas-tulip-phd-chief-executive-officer</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/fluoropharma-names-dr-thomas-tulip-phd-chief-executive-officer</guid>
      <pubDate>Tue, 29 Dec 2015 21:43:29 GMT</pubDate>
      <description>FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer.</description>
    </item>
    <item>
      <title>Cardiology Product Potential, Clinical Trial Progress and Capital Acquisition Success Drive the Company&apos;s Next Moves</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/cardiology-product-potential-clinical-trial-progress-and-capital-acquisition-success-drive-the-companys-next-moves</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/cardiology-product-potential-clinical-trial-progress-and-capital-acquisition-success-drive-the-companys-next-moves</guid>
      <pubDate>Fri, 23 Oct 2015 12:04:37 GMT</pubDate>
      <description>Cardiology Product Potential, Clinical Trial Progress and Capital Acquisition Success Drive the Company&apos;s Next Moves.</description>
    </item>
    <item>
      <title>Healthcare Industry Veteran, Thomas Tulip, Joins FluoroPharma Medical, Inc.</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/healthcare-industry-veteran-thomas-tulip-joins-fluoropharma-medical-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/healthcare-industry-veteran-thomas-tulip-joins-fluoropharma-medical-inc</guid>
      <pubDate>Tue, 06 Oct 2015 14:45:30 GMT</pubDate>
      <description>Healthcare Industry Veteran, Thomas Tulip, Joins FluoroPharma Medical, Inc..</description>
    </item>
    <item>
      <title>OTC Markets Group Welcomes Newly Verified OTCQB Companies – April 23</title>
      <link>https://6ix.com/company/fluoropharma-medical/news/otc-markets-group-welcomes-newly-verified-otcqb-companies-april-23-1</link>
      <guid isPermaLink="true">https://6ix.com/company/fluoropharma-medical/news/otc-markets-group-welcomes-newly-verified-otcqb-companies-april-23-1</guid>
      <pubDate>Thu, 23 Apr 2015 11:00:00 GMT</pubDate>
      <description>OTC Markets Group Welcomes Newly Verified OTCQB Companies – April 23.</description>
    </item>
  </channel>
</rss>